Clinical trial
Randomized and Multicenter Clinical Trial to Evaluate the Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy in Patients With Risk of Aspergillosis
NCT04238884 is registered in ClinicalTrials.gov with Instituto de Investigación Hospital Universitario La Paz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized and Multicenter Clinical Trial to Evaluate the Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy in Patients With Risk of Aspergillosis
- Lead sponsor
- Instituto de Investigación Hospital Universitario La Paz
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 2, 2020
- Completion date
- December 31, 2022
- Enrollment
- 146 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.